­

Healthcare Radius ( 08th Feb 2023) – Akums Launches Type 2 Diabetes Drug, Lobeglitazone

By |February 11th, 2023|

Read More
 0

Medical Dialogues ( 06th Feb 2023) – Akums Drugs and Pharma Bags DCGI Nod to Unveil Type 2 Diabetes Drug Lobeglitazone in India

By |February 11th, 2023|

Read More
 0

Biospectrum India ( 06th Feb 2023) – Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance

By |February 11th, 2023|

Read More
 0

ET Healthworld ( 06th Feb 2023) – Akums gets DCGI nod to launch anti-diabetic drug Lobeglitazone in India

By |February 11th, 2023|

Read More
 0

Express Pharma ( 06th Feb 2023) – Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India

By |February 11th, 2023|

Read More
 0

BW Healthcare World ( 06th Feb 2023) – Akums Receives DCGI Approval To Launch Diabetes Drug For Type 2 Diabetics

By |February 11th, 2023|

Read More
 0

Money Control ( 06th Feb 2023) – Akums gets DCGI nod to launch drugs for uncontrolled diabetes in India

By |February 11th, 2023|

Read More
 0

Financial Express (06th Feb 2023) – Akums Pharma gets DCGI approval to launch drug for type 2 diabetic patients

By |February 11th, 2023|

Read More
 0

The Healthsite ( 02nd Feb 2023) – Health Budget 2023: Nothing Much For Women’s Healthcare

By |February 3rd, 2023|

Read More
 0

Healthcare Radius ( 02nd Feb 2023) – Budget Reactions: Industry Welcomes Union Budget 2023 Provisions

By |February 3rd, 2023|

Read More
 0

Akums Drugs & Pharmaceuticals Ltd. India is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing pharmaceutical company. Akums has rapidly emerged as the premier integrated pharmaceutical company in India. Its business focus is on manufacturing & marketing of pharmaceutical products along with serving clients across the globe.
Copyright 2023 Akums | All Rights Reserved